vs
Atlanta Braves Holdings, Inc.（BATRA）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Atlanta Braves Holdings, Inc.的1.2倍（$75.5M vs $61.3M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 17.6%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -52.5%）
亚特兰大勇士控股有限公司是一家体育娱乐类控股企业，核心持有并运营美国职业棒球大联盟旗下的亚特兰大勇士队，同时开展场馆周边商住开发、活动承办、周边商品销售及传媒业务，服务美国东南部及全球棒球迷。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
BATRA vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.2倍
$61.3M
营收增速更快
PBYI
高出10.1%
17.6%
两年增速更快
PBYI
近两年复合增速
-52.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.3M | $75.5M |
| 净利润 | $-41.4M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | -81.2% | 22.7% |
| 净利率 | -67.6% | — |
| 营收同比 | 17.6% | 27.7% |
| 净利润同比 | -116.7% | — |
| 每股收益（稀释后） | $-0.64 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BATRAPBYI
| Q4 25 | $61.3M | $75.5M | ||
| Q3 25 | $311.5M | $54.5M | ||
| Q2 25 | $312.4M | $52.4M | ||
| Q1 25 | $47.2M | $46.0M | ||
| Q4 24 | $52.1M | $59.1M | ||
| Q3 24 | $290.7M | $80.5M | ||
| Q2 24 | $282.9M | $47.1M | ||
| Q1 24 | — | $43.8M |
净利润BATRAPBYI
| Q4 25 | $-41.4M | — | ||
| Q3 25 | $30.0M | $8.8M | ||
| Q2 25 | $29.5M | $5.9M | ||
| Q1 25 | $-41.4M | $3.0M | ||
| Q4 24 | $-19.1M | — | ||
| Q3 24 | $10.0M | $20.3M | ||
| Q2 24 | $29.1M | $-4.5M | ||
| Q1 24 | — | $-4.8M |
毛利率BATRAPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率BATRAPBYI
| Q4 25 | -81.2% | 22.7% | ||
| Q3 25 | 12.5% | 17.6% | ||
| Q2 25 | 13.4% | 12.7% | ||
| Q1 25 | -94.2% | 8.7% | ||
| Q4 24 | -35.8% | 22.6% | ||
| Q3 24 | 2.2% | 27.4% | ||
| Q2 24 | 8.8% | -4.6% | ||
| Q1 24 | — | -5.3% |
净利率BATRAPBYI
| Q4 25 | -67.6% | — | ||
| Q3 25 | 9.6% | 16.2% | ||
| Q2 25 | 9.4% | 11.2% | ||
| Q1 25 | -87.7% | 6.5% | ||
| Q4 24 | -36.7% | — | ||
| Q3 24 | 3.4% | 25.2% | ||
| Q2 24 | 10.3% | -9.6% | ||
| Q1 24 | — | -11.0% |
每股收益（稀释后）BATRAPBYI
| Q4 25 | $-0.64 | $0.26 | ||
| Q3 25 | $0.47 | $0.17 | ||
| Q2 25 | $0.46 | $0.12 | ||
| Q1 25 | $-0.66 | $0.06 | ||
| Q4 24 | $-0.29 | $0.40 | ||
| Q3 24 | $0.16 | $0.41 | ||
| Q2 24 | $0.46 | $-0.09 | ||
| Q1 24 | — | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $99.9M | $97.5M |
| 总债务越低越好 | $738.6M | $22.7M |
| 股东权益账面价值 | $526.0M | $130.3M |
| 总资产 | $1.6B | $216.3M |
| 负债/权益比越低杠杆越低 | 1.40× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资BATRAPBYI
| Q4 25 | $99.9M | $97.5M | ||
| Q3 25 | $82.2M | $94.4M | ||
| Q2 25 | $96.2M | $96.0M | ||
| Q1 25 | $244.7M | $93.2M | ||
| Q4 24 | $110.1M | $101.0M | ||
| Q3 24 | $100.9M | $96.7M | ||
| Q2 24 | $121.2M | $96.8M | ||
| Q1 24 | — | $107.2M |
总债务BATRAPBYI
| Q4 25 | $738.6M | $22.7M | ||
| Q3 25 | $759.9M | $34.0M | ||
| Q2 25 | $703.1M | $45.3M | ||
| Q1 25 | $699.5M | $56.7M | ||
| Q4 24 | $617.1M | $68.0M | ||
| Q3 24 | $640.1M | $79.3M | ||
| Q2 24 | $600.0M | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益BATRAPBYI
| Q4 25 | $526.0M | $130.3M | ||
| Q3 25 | $560.3M | $115.3M | ||
| Q2 25 | $522.8M | $104.7M | ||
| Q1 25 | $486.1M | $97.1M | ||
| Q4 24 | $524.2M | $92.1M | ||
| Q3 24 | $530.4M | $71.1M | ||
| Q2 24 | $512.7M | $48.5M | ||
| Q1 24 | — | $51.0M |
总资产BATRAPBYI
| Q4 25 | $1.6B | $216.3M | ||
| Q3 25 | $1.7B | $202.9M | ||
| Q2 25 | $1.7B | $194.9M | ||
| Q1 25 | $1.7B | $196.2M | ||
| Q4 24 | $1.5B | $213.3M | ||
| Q3 24 | $1.6B | $220.7M | ||
| Q2 24 | $1.6B | $205.0M | ||
| Q1 24 | — | $214.1M |
负债/权益比BATRAPBYI
| Q4 25 | 1.40× | 0.17× | ||
| Q3 25 | 1.36× | 0.30× | ||
| Q2 25 | 1.34× | 0.43× | ||
| Q1 25 | 1.44× | 0.58× | ||
| Q4 24 | 1.18× | 0.74× | ||
| Q3 24 | 1.21× | 1.12× | ||
| Q2 24 | 1.17× | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流BATRAPBYI
| Q4 25 | $26.4M | $14.4M | ||
| Q3 25 | $-88.8M | $9.7M | ||
| Q2 25 | $-8.1M | $14.1M | ||
| Q1 25 | $95.8M | $3.6M | ||
| Q4 24 | $28.9M | $15.6M | ||
| Q3 24 | $-69.0M | $11.0M | ||
| Q2 24 | $-34.3M | $1.0M | ||
| Q1 24 | — | $11.2M |
自由现金流BATRAPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | $-82.3M | $14.1M | ||
| Q1 25 | $76.3M | $3.6M | ||
| Q4 24 | $16.8M | $15.6M | ||
| Q3 24 | $-85.5M | $11.0M | ||
| Q2 24 | $-64.1M | $1.0M | ||
| Q1 24 | — | — |
自由现金流率BATRAPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | -26.3% | 26.8% | ||
| Q1 25 | 161.5% | 7.7% | ||
| Q4 24 | 32.3% | 26.4% | ||
| Q3 24 | -29.4% | 13.7% | ||
| Q2 24 | -22.7% | 2.1% | ||
| Q1 24 | — | — |
资本支出强度BATRAPBYI
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 23.7% | 0.0% | ||
| Q1 25 | 41.3% | 0.1% | ||
| Q4 24 | 23.2% | 0.0% | ||
| Q3 24 | 5.7% | 0.0% | ||
| Q2 24 | 10.5% | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率BATRAPBYI
| Q4 25 | — | — | ||
| Q3 25 | -2.96× | 1.10× | ||
| Q2 25 | -0.28× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -6.89× | 0.54× | ||
| Q2 24 | -1.18× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BATRA
| Baseball | $34.8M | 57% |
| Mixed Use Development Segment | $26.5M | 43% |
PBYI
暂无分部数据
